首页> 外文期刊>Pharmaceutical development and technology >Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system
【24h】

Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system

机译:壳聚糖/卵磷脂脂质体纳米粒子作为口服胰岛素递送系统

获取原文
获取原文并翻译 | 示例
           

摘要

ABSTRACT In the present work, insulin-chitosan polyelectrolyte complexes associated to lecithin liposomes were investigated as a new carrier for oral delivery of insulin. The preparation was characterized in terms of particle size, zeta potential and encapsulation efficiency. Surface tension measurements revealed that insulin-chitosan polyelectrolyte complexes have some degree of hydrophobicity and should be added to lecithin liposomal dispersion and not the vice versa to prevent their adsorption on the surface. Stability of insulin was enhanced when it was associated to liposomes. Significant reduction of blood glucose levels was noticed after oral administration of liposomal preparation to streptozotocin diabetic rats compared to control. The hypoglycemic activity was more prolonged compared to subcutaneously administered insulin.
机译:摘要在本作工作中,研究了与卵磷脂脂质体相关的胰岛素 - 壳聚糖聚电解质复合物作为胰岛素口服递送的新载体。 在粒度,Zeta电位和封装效率方面表征了制剂。 表面张力测量显示,胰岛素 - 壳聚糖聚电解质配合物具有一定程度的疏水性,并且应加入卵磷脂脂质体分散体,而不是反之亦然,以防止它们在表面上吸附。 当与脂质体相关时,增强了胰岛素的稳定性。 与对照相比,口服对链脲佐菌素糖尿病大鼠口服脂质体制术后,注意到血糖水平的显着降低。 与皮下给药的胰岛素相比,降血糖活性更长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号